Clinical Trials Browser

NIH × Interventional × ofatumumab × Clear all

NCT01145209 2023-11-28

Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL

Phase 2 Completed

32 enrolled 16 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell